Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Robins

Showing results (161-170 of 221) with videos related to

Pageof 23
Sort By:
Chest|October 1, 1986
Bronchoscopic and radiologic features of Kaposi's sarcoma involving the respiratory systemJ D Zibrak, R C Silvestri, P Costello, et al.
Clinical and Experimental Immunology|August 8, 2002
Loss of cytomegalovirus-specific immunological memory in a patient with thymomaA P Huissoon, G Davies, R A Cox, et al.
International Journal of Cancer|May 15, 1981
Report on international comparative evaluation of possible value of assays for immune complexes for diagnosis of human breast cancerR B Herberman, M Bordes, P H Lambert, et al.
Cancer Research|October 1, 1991
Antitumor immune response and interleukin 2 production induced in colorectal cancer patients by immunization with human monoclonal anti-idiotypic antibodyR A Robins, G W Denton, J D Hardcastle, et al.
The Journal of Pathology|January 1, 1997
Interleukin-8 and inducible nitric oxide synthase mRNA levels in inflammatory bowel disease at first presentationJ M McLaughlan, R Seth, G Vautier, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1982
Rat NK cells active against lymphoma and sarcoma tumor cells are probably identicalC G Brooks, G R Flannery, D A Cantrell, et al.
Gut|September 16, 1999
Increased activation of lymphocytes infiltrating primary colorectal cancers following immunisation with the anti-idiotypic monoclonal antibody 105AD7C A Maxwell-Armstrong, L G Durrant, R A Robins, et al.
Alimentary Pharmacology & Therapeutics|May 20, 2024
Randomised clinical trial: Design of the SYNERGY-NASH phase 2b trial to evaluate tirzepatide as a treatment for metabolic dysfunction-associated steatohepatitis and modification of screening strategy to reduce screen failuresRaj Vuppalanchi, Rohit Loomba, Arun J Sanyal, et al.
Journal of Leukocyte Biology|February 26, 2004
Endothelial monocyte-activating polypeptide-II (EMAP-II): a novel inducer of lymphocyte apoptosisJ C Murray, Y M Heng, P Symonds, et al.
British Journal of Cancer|April 1, 1990
A bispecific monoclonal antibody against methotrexate and a human tumour associated antigen augments cytotoxicity of methotrexate-carrier conjugateM V Pimm, R A Robins, M J Embleton, et al.
Pageof 23

Showing results (161-170 of 221) with videos related to

Sort By:
Pageof 23
Chest|October 1, 1986
Bronchoscopic and radiologic features of Kaposi's sarcoma involving the respiratory systemJ D Zibrak, R C Silvestri, P Costello, et al.
Clinical and Experimental Immunology|August 8, 2002
Loss of cytomegalovirus-specific immunological memory in a patient with thymomaA P Huissoon, G Davies, R A Cox, et al.
International Journal of Cancer|May 15, 1981
Report on international comparative evaluation of possible value of assays for immune complexes for diagnosis of human breast cancerR B Herberman, M Bordes, P H Lambert, et al.
Cancer Research|October 1, 1991
Antitumor immune response and interleukin 2 production induced in colorectal cancer patients by immunization with human monoclonal anti-idiotypic antibodyR A Robins, G W Denton, J D Hardcastle, et al.
The Journal of Pathology|January 1, 1997
Interleukin-8 and inducible nitric oxide synthase mRNA levels in inflammatory bowel disease at first presentationJ M McLaughlan, R Seth, G Vautier, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1982
Rat NK cells active against lymphoma and sarcoma tumor cells are probably identicalC G Brooks, G R Flannery, D A Cantrell, et al.
Gut|September 16, 1999
Increased activation of lymphocytes infiltrating primary colorectal cancers following immunisation with the anti-idiotypic monoclonal antibody 105AD7C A Maxwell-Armstrong, L G Durrant, R A Robins, et al.
Alimentary Pharmacology & Therapeutics|May 20, 2024
Randomised clinical trial: Design of the SYNERGY-NASH phase 2b trial to evaluate tirzepatide as a treatment for metabolic dysfunction-associated steatohepatitis and modification of screening strategy to reduce screen failuresRaj Vuppalanchi, Rohit Loomba, Arun J Sanyal, et al.
Journal of Leukocyte Biology|February 26, 2004
Endothelial monocyte-activating polypeptide-II (EMAP-II): a novel inducer of lymphocyte apoptosisJ C Murray, Y M Heng, P Symonds, et al.
British Journal of Cancer|April 1, 1990
A bispecific monoclonal antibody against methotrexate and a human tumour associated antigen augments cytotoxicity of methotrexate-carrier conjugateM V Pimm, R A Robins, M J Embleton, et al.
Pageof 23